Hui Yang, Ph.D., is the Co-Founder and Chief Scientific Advisor of HuidaGene and currently serves as Principal Investigator at Center for Excellence in Brain Science and Intelligence Technology of the Chinese Academy of Sciences and Head of the Non-Human Primate Disease Model Research Group at the State Key Laboratory of Neuroscience. Dr. Yang’s research work focuses on the discovery and development of CRISPR/Cas- and other RNA-guided nucleases-mediated gene editing technologies through PRECISE^®(Platform of Rational Engineering of Compact nuclease Identification by Synergic Expertise) platform, including the optimization of DNA and RNA gene editing tools and development of targeted gene therapies in neurology, ophthalmology, otology, myology, and hepatology. Dr. Yang has received the Ho Leung Ho Lee Foundation Prize for Scientific and Technological Progress, Outstanding Achievement Award of Wuxi AppTec Life Science and Chemistry Award, VCANBIO Award for Biosciences and Medicine, Ray Wu Prize, and has been named Young Top-Notch Talents in Shanghai. Dr. Yang has published over 100 scientific manuscripts, national meeting presentations and abstracts in top international peer-reviewed journals, including Science, Nature, Cell, Nature Methods, Nature Communications, Nature Biotechnology, Nature Neuroscience, Nature Cell Biology, National Science Review, Protein & Cell, and Science Translational Medicine. Dr. Yang received his Ph.D. in Development Biology from the Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences with postdoctoral training at Whitehead Institute of Massachusetts Institute of Technology and a B.S. in Biology at Shanghai Jiao Tong University. 

Allen C. Ho, MD, FACS, FASRS, is an internationally recognized retina specialist specializing in patient care and is a leader in the development of new medical and surgical treatments including gene and cell therapies for retinal diseases such as age-related macular degeneration, other macular diseases, diabetic retinopathy and surgical retinal diseases. Dr. Ho serves as Attending Surgeon at Wills Eye Hospital and Director of Retina Research, Co-Director of the Retina Service at Wills Eye Hospital, and Scientific Advisory Board member at the Ophthalmic Devices Committee of the U.S. Food and Drug Administration (FDA). He is former Co-Director of the Wills Retina Fellowship, widely recognized as the premier retina training program in the country. Dr. Ho has authored over 300 scientific publications and is Editor-in-Chief of Current Opinion in Ophthalmology and Chief Medical Editor of Retina Today. He has received the American Academy of Ophthalmology’s Secretariat Award, AAO Senior Honor Award, American Society of Retina Specialists Senior Honor Award and has been named a Charter Member of The Retina Hall of Fame and The Ophthalmologist’s Top 100 Most Influential People in Ophthalmology on multiple occasions. Dr. Ho is a Phi Beta Kappa graduate of Cornell University College of Arts and Sciences, graduated from Columbia University College of Physicians and Surgeons, and was elected Co-Chief Resident during his ophthalmology residency at Wills Eye Hospital. He completed a Fellowship in Vitreoretinal Diseases at Manhattan Eye, Ear and Throat Hospital in New York.

Charles Wykoff, M.D., Ph.D., is a board-certified Medical and Surgical Retina Specialist and ophthalmologist with Retina Consultants of Texas (RCTX) and serves as Director of Research at RCTX and the Greater Houston Retina Research Foundation (GHRRF), Chairman of the Research and Clinical Trials Subcommittee, Retina Consultants of America, and elected Deputy Chair of Ophthalmology for the Blanton Eye Institute of Houston Methodist Hospital. Dr. Wykoff has extensive expertise in translational research and clinical trial design with the focus on angiogenesis and retinal vascular diseases. Dr. Wykoff has published over 160 peer-reviewed scientific manuscripts and frequently speaks at national and international academic meetings. Dr.Wykoff and is a member of the American Academy of Ophthalmology (AAO), Association for Research in Vision and Ophthalmology (ARVO), American Society of Retina Specialists (ASRS) and American College of Surgeons (ACS). Dr.Wykoff graduated Phi Beta Kappa from MIT, received his PhD from Oxford University in England while on a Marshall Scholarship, and his Medical Degree from Harvard Medical School. As a medical student he co-authored the book Fighting Global Blindness. Dr. Wykoff was awarded a Heed Fellowship and the Ronald G. Michels Fellowship Award at Bascom Palmer Eye Institute, American Academy of Ophthalmology Secretariat and Achievement Awards and American Society of Retina Specialists Senior Honor and Young Investigator Awards.